Write For Us

Why is Germany's CureVac vaccine just 48% effective? | Covid-19 Special

Sponsored Post Vitamin D2 Canada Persia
90 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
CureVac's COVID-19 jab did not turn out what many hoped it would be. That's despite using the same messenger RNA technology as rivals Moderna and BioNTech-Pfizer. CureVac aimed to produce its vaccine primarily for developing countries – as it can be stored more easily than other products. And despite disappointing trial-results the company is sticking to the plan.

Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1

For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews
►Instagram: https://www.instagram.com/dwnews
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch

#CureVac #Covid19 #coronavirus
Category
Europe
Tags
curevac, vaccine, vaccines
Sign in or sign up to post comments.
Be the first to comment